Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma
PLOS ONE · 19.09.2023 · 18 (9) · e0291645
DOI: 10.1371/journal.pone.0291645 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 19.09.2023. Verfasst von Qian Feng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The Second Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Research Project of Jiangxi Education Department, Science and Technology Research Project of Jiangxi Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma is one of the most common malignancies worldwide, representing a big health-care challenge globally. M2-like macrophages are significantly correlated with tumor progression, metastasis and treatment resistance.
Methods
Integrative 10 machine learning algorithms were performed to developed a M2-like macrophage related prognostic signature (MRPS). Single-cell RNA-sequencing analysis was performed to dissect the ecosystem of HCC. Several approaches, including TIDE score, immunophenoscore, TMB score and tumor escape score were used to evaluate the predictive role of MRPS in immunology response.
Results
The optimal MRPS constructed by the combination of stepCox + superPC algorithm served as an independent risk factor and showed stable and powerful performances in predicting the overall survival rate of HCC patients with 2-, 3-, and 4-year AUCs of 0. 763, 0.751, and 0.699 in TCGA cohort. HCC patients with low risk score possessed a more interaction of immunoactivated cells, including NK, CD8 + cytotoxic T, and activated B, and a less interaction of immunosuppressive cells, including Treg, CD4 + exhauster T, and M2-like macrophage. Low risk score indicated a higher PD1&CTLA4 immunophenoscore, higher TMB score, lower TIDE score and lower tumor escape score in HCC, suggesting a better immunotherapy response. The IC50 value of docetaxel, gemcitabine, crizotinib and Osimertinib in HCC with high risk score were lower versus that with low risk score. HCC patients with high risk score had a higher score of cancer-related hallmarks, including angiogenesis, DNA repair, EMT, glycolysis, and NOTCH signaling.
Conclusion
Our study proposed a novel MRPS for predicting the prognosis, ecosystem and immunotherapy response in HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Emergency, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Linquan Wu
Förderung
- Science and Technology Research Project of Jiangxi Education Department
- Science and Technology Research Project of Jiangxi Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Feng, Q., Lu, H., & Wu, L. (2023). Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma. PLOS ONE, 18(9), e0291645. https://doi.org/10.1371/journal.pone.0291645
Vancouver
Feng Q, Lu H, Wu L. Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma. PLOS ONE. 2023;18(9):e0291645. doi:10.1371/journal.pone.0291645
BibTeX
@article{Feng2023,
author = {Feng, Qian and Lu, Hongcheng and Wu, Linquan},
title = {Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {9},
pages = {e0291645},
doi = {10.1371/journal.pone.0291645}
}
EUVIMED